Research ArticleCARDIOVASCULAR
Bepridil, an Antiarrhythmic Drug, Opens Mitochondrial KATP Channels, Blocks Sarcolemmal KATP Channels, and Confers Cardioprotection
Toshiaki Sato, Alexandre D. T. Costa, Tomoaki Saito, Takehiko Ogura, Hideyuki Ishida, Keith D. Garlid and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics January 2006, 316 (1) 182-188; DOI: https://doi.org/10.1124/jpet.105.094029
Toshiaki Sato
Alexandre D. T. Costa
Tomoaki Saito
Takehiko Ogura
Hideyuki Ishida
Keith D. Garlid
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleCARDIOVASCULAR
Bepridil, an Antiarrhythmic Drug, Opens Mitochondrial KATP Channels, Blocks Sarcolemmal KATP Channels, and Confers Cardioprotection
Toshiaki Sato, Alexandre D. T. Costa, Tomoaki Saito, Takehiko Ogura, Hideyuki Ishida, Keith D. Garlid and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics January 1, 2006, 316 (1) 182-188; DOI: https://doi.org/10.1124/jpet.105.094029
Research ArticleCARDIOVASCULAR
Bepridil, an Antiarrhythmic Drug, Opens Mitochondrial KATP Channels, Blocks Sarcolemmal KATP Channels, and Confers Cardioprotection
Toshiaki Sato, Alexandre D. T. Costa, Tomoaki Saito, Takehiko Ogura, Hideyuki Ishida, Keith D. Garlid and Haruaki Nakaya
Journal of Pharmacology and Experimental Therapeutics January 1, 2006, 316 (1) 182-188; DOI: https://doi.org/10.1124/jpet.105.094029
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement